Stephen B. Williams

Also affiliated with University of Southampton, The University of Texas Medical Branch at Galveston

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Data Sharing Under the General Data Protection Regulation”.

Data Sharing Under the General Data Protection Regulation

Hypertension(2021)10.1161/hypertensionaha.120.16340

N/A

5.8DataRank · unranked

133 citations

Dara Hallinan, Rolf Apweiler, Angel Argiles, Joachim Beige, Ariela Benigni +37 more

Intraoperative and early postoperative complications in postchemotherapy retroperitoneal lymphadenectomy among patients with germ cell tumors using validated grading classifications

Cancer(2020)10.1002/cncr.33051

N/A

0DataRank · unranked

14 citations

Andrew G. McIntosh, Chalairat Suk‐Ouichai, Luis Segarra, Levi C. Holland, Bryan Fellman +9 more

Impact of Diagnosing Urologists and Hospitals on the Use of Radical Cystectomy

European Urology Open Science(2020)10.1016/j.euros.2020.06.001

N/A

0DataRank · unranked

1 citations

Yong Shan, Hemalkumar B. Mehta, Zachary Klaassen, Douglas S. Tyler, Jacques Baillargeon +7 more

Cost-effectiveness analysis of neoadjuvant immune checkpoint inhibition (ICI) versus cisplatin-based chemotherapy (CBC) in muscle-invasive bladder cancer (MIBC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.419

N/A

0DataRank · unranked

0 citations

Yong Shan, Richard E. Nelson, Sapna Kaul, John L. Gore, Petros Grivas +2 more

Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients

Urologic Oncology Seminars and Original Investigations(2022)10.1016/j.urolonc.2022.04.013

N/A

0DataRank · unranked

14 citations

Minhyung Kim, Steven G. Widen, Alexander Yu, Gloria C. Galván, Yunhee Choi-Kuaea +12 more

Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorship

Urologic Oncology Seminars and Original Investigations(2022)10.1016/j.urolonc.2022.10.015

N/A

0DataRank · unranked

4 citations

Zhigang Duan, Kelly K. Bree, Akshay Sood, Hui Zhao, Niyati Lobo +8 more

Characterizing molecular subtypes of high-risk nonmuscle-invasive bladder cancer in African American patients.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.527

N/A

0DataRank · unranked

0 citations

Sungyong You, Minhyung Kim, Steven G. Widen, Alexander Yu, Eduardo Eyzaguirre +10 more

Re: Sequential Intravesical Gemcitabine and Docetaxel for Bacillus Calmette-Guérin-naïve High-risk Nonmuscle-invasive Bladder Cancer

European Urology(2022)10.1016/j.eururo.2022.08.024

N/A

0DataRank · unranked

0 citations

Ali A. Nasrallah, Stephen B. Williams, Mehraban Kavoussi

Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and Meta-analysis of Perioperative, Oncological, and Quality of Life Outcomes Using Randomized Controlled Trials

European Urology(2023)10.1016/j.eururo.2023.04.004

N/A

0DataRank · unranked

106 citations

Joanna Wong, Wei Phin Tan, Thiara Rupasinghe, Wei Shen Tan, Stephen B. Williams +10 more

Background and Update for ECOG-ACRIN EA8212: A Randomized Phase 3 Trial of Intravesical Bacillus Calmette-Guérin (BCG) Versus Intravesical Docetaxel and Gemcitabine Treatment in BCG-naïve High-grade Non–muscle-invasive Bladder Cancer (BRIDGE)

European Urology Focus(2023)10.1016/j.euf.2023.06.006

N/A

0DataRank · unranked

49 citations

Xiangying Chu, Noah M. Hahn, Eugene J. Pietzak, Angela B. Smith, Daniel H. Shevrin +9 more

A SEER-Medicare Based Quality Score for Patients With Metastatic Upper Tract Urothelial Carcinoma

Clinical Genitourinary Cancer(2023)10.1016/j.clgc.2023.06.010

N/A

0DataRank · unranked

5 citations

Yong Shan, Courtney A. Stewart, Karim Chamie, Matthew D. Galsky, Stephen A. Boorjian +3 more

The impact of blue light cystoscopy use among patients with non-muscle invasive bladder cancer in an equal access setting.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.461

N/A

0DataRank · unranked

0 citations

Lin Gu, Claire Trustram Eve, Joshua Parrish, Amanda Marie De Hoedt, Chad M. McKee +4 more

Presence of an Artificial Intelligence–powered Predictive Biomarker Is Associated with a Poor Response to Intravesical Bacillus Calmette-Guerin but Not to Intravesical Sequential Gemcitabine/Docetaxel in Patients with High-grade Non–muscle-invasive Bladder Cancer

European Urology Oncology(2025)10.1016/j.euo.2025.04.006

N/A

0DataRank · unranked

6 citations

Ian M. McElree, Saum Ghodoussipour, Vivek Nimgaonkar, Viswesh Krishna, Joon Kyung Kim +15 more